vindesine has been researched along with Complication, Postoperative in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adibi, A; Azhir, A; Reisi, N; Taheri, D | 1 |
| Funakoshi, Y; Kadota, Y; Kawamura, S; Koma, M; Maeda, H; Matsubara, Y; Takeda, S | 1 |
| Bergerat, JP; Caillard, S; Chenard, MP; Ellero, B; Epailly, E; Fohrer, C; Herbrecht, R; Kessler, R; Koumarianou, A; Lioure, B; Lutun, P; Maloisel, F; Meyer, C; Moulin, B; Natarajan-Ame, S; Woehl-Jaeglé, ML; Wolf, P | 1 |
| Cerrina, J; Chapelier, AR; Dartevelle, PG; Ladurie, FL; Lenot, B; Macchiarini, P; Monnet, I; Parquin, F; Rebischung, JL; Vannetzel, JM | 1 |
| Kobori, O; Muto, T; Nagawa, H; Seto, Y | 1 |
| DeAngelis, LM; Olson, JD; Riedel, E | 1 |
| Breau, JL; Clavier, J; Gres, JJ; Israël, L; Lerebours-Pigeonnière, G; Morère, JF; Nouvet, G; Raut, Y; Zabbe, C | 1 |
| Herfarth, C; Herrmann, R; Lehner, B; Raeth, U; Schlag, P; Schwarz, V | 1 |
| Flanagan, MM; Graeber, GM; Pass, HI; Rosenberg, JC; Roth, JA; Steinberg, S | 1 |
1 trial(s) available for vindesine and Complication, Postoperative
| Article | Year |
|---|---|
Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Esophageal Neoplasms; Humans; Postoperative Complications; Random Allocation; Vindesine | 1988 |
8 other study(ies) available for vindesine and Complication, Postoperative
| Article | Year |
|---|---|
Post transplant anaplastic large T-cell lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Creatinine; Cyclophosphamide; Cyclosporine; Doxorubicin; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphoma, Large-Cell, Anaplastic; Male; Mycophenolic Acid; Postoperative Complications; Prednisone; Vindesine | 2009 |
Fall in diffusing capacity associated with induction therapy for lung cancer: a predictor of postoperative complication?
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbon Monoxide; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Empyema, Pleural; Female; Forced Expiratory Volume; Forecasting; Humans; Hypoxia; Lung Neoplasms; Male; Middle Aged; Mitomycin; Pneumonectomy; Pneumonia; Postoperative Complications; Predictive Value of Tests; Pulmonary Atelectasis; Pulmonary Diffusing Capacity; Pulmonary Embolism; Pulmonary Gas Exchange; Radiotherapy; Remission Induction; Respiratory Distress Syndrome; Respiratory Insufficiency; Retrospective Studies; Risk Factors; Vinblastine; Vindesine; Vinorelbine; Vital Capacity | 2006 |
Long-term survival in post-transplant lymphoproliferative disorders with a dose-adjusted ACVBP regimen.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphoproliferative Disorders; Male; Middle Aged; Organ Transplantation; Postoperative Complications; Prednisone; Survival Rate; Treatment Outcome; Vincristine; Vindesine | 2006 |
Extended operations after induction therapy for stage IIIb (T4) non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Loss, Surgical; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Incidence; Length of Stay; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Mitomycins; Neoplasm Staging; Pneumonectomy; Postoperative Complications; Proportional Hazards Models; Remission Induction; Survival Rate; Time Factors; Vinblastine; Vindesine; Vinorelbine | 1994 |
An experience of treatment for patients with thoracic esophageal cancer invading adjacent organs.
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Humans; Lymph Node Excision; Middle Aged; Neoplasm Invasiveness; Postoperative Complications; Pulmonary Veins; Radiotherapy Dosage; Remission Induction; Survival Rate; Thorax; Trachea; Vena Cava, Superior; Vindesine | 1997 |
Long-term outcome of low-grade oligodendroglioma and mixed glioma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Cyclophosphamide; Disease-Free Survival; Female; Follow-Up Studies; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Oligodendroglioma; Postoperative Complications; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Treatment Outcome; Vindesine | 2000 |
Preliminary results of preoperative chemotherapy with a combination of platinum-bleomycin administered in 5-day cycles in carcinoma of the bronchus.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchial Neoplasms; Carcinoma, Squamous Cell; Combined Modality Therapy; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Platinum; Postoperative Complications; Vindesine | 1986 |
[Preoperative chemotherapy in esophageal cancer: an advantage or danger for surgical intervention?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Drug Evaluation; Esophageal Neoplasms; Humans; Postoperative Complications; Risk Factors; Vindesine | 1987 |